Amantadine And NotOlivier Rascol
List of bibliographic references
Number of relevant bibliographic references: 17.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000383 | Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic Antidyskinetic Effects of Topiramate and Amantadine in Animal Models of Parkinson's Disease |
| 000771 | Francisco De Assis Aquino Gondim [Brésil] ; Helida A. Costa [Brésil] ; Tauily C. D. Taunay [Brésil] ; Gisele R. De Oliveira [Brésil] ; Jamile Magalhaes Ferreira [Brésil] ; Francisco H. Rola [Brésil] | Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson's Disease |
| 000985 | Elisabeth Wolf [Autriche] ; Klaus Seppi [Autriche] ; Regina Katzenschlager [Autriche] ; Guenter Hochschorner [Autriche] ; Gerhard Ransmayr [Autriche] ; Petra Schwingenschuh [Autriche] ; Erwin Ott [Autriche] ; Iris Kloiber [Autriche] ; Dietrich Haubenberger [Autriche] ; Eduard Auff [Autriche] ; Werner Poewe [Autriche] | Long-Term Antidyskinetic Efficacy of Amantadine in Parkinson's Disease |
| 001374 | Kenichi Kashihara [Japon] ; Takaki Imamura [Japon] | Amantadine May Reverse Punding in Parkinson's Disease- : Observation in a Patient |
| 001620 | Dariusz Koziorowski [Pologne] ; Andrzej Friedman [Pologne] | Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease |
| 001B27 | Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; David Flamarich [Espagne] | Effect of amantadine in essential tremor : A randomized, placebo-controlled trial |
| 001C31 | Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli [Italie] ; Edna Schechtman [Israël] ; Ala Miniowich [Israël] ; Rosa Strugatsky [Israël] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Carlo Rossi [Italie] ; Colin Klein [Israël] ; J. Martin Rabey [Israël] | Association between amantadine and the onset of dementia in parkinson's disease |
| 001D25 | Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Eugene L. Roberts [États-Unis] ; Abraham Lieberman [États-Unis] | Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine : Report of a case series |
| 002254 | Yoshiaki Furukawa [Canada] ; James J. Filiano [États-Unis] ; Stephen J. Kish [Canada] | Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations |
| 002539 | Georg Ebersbach [Allemagne] | An artist's view of drug-induced hallucinosis |
| 002863 | Amantadine and other antiglutamate agents | |
| 002973 | Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie] | Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study |
| 002C52 | E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bosch [Autriche] ; Werner Poewe [Autriche] | Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's Disease |
| 002C67 | V. G. H. Evidente [États-Unis, Philippines] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; J. G. Hentz [États-Unis] ; K. Gwinn-Hardy [États-Unis] | Amantadine is beneficial in restless legs syndrome |
| 002C98 | S. A. Factor [États-Unis] ; E. S. Molho [États-Unis] | Transient benefit of amantadine in Parkinson's disease : The facts about the myth |
| 003082 | T. Van Laar [Pays-Bas] ; G.-J. Lammers [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; J. J. Gerritsen [Pays-Bas] ; A. E. Meinders [Pays-Bas] | Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion |
| 003085 | P. J. Blanchet [États-Unis] ; S. Konitsiotis [États-Unis] ; T. N. Chase [États-Unis] | Amantadine reduces levodopa-induced dyskinesias in Parkinsonian monkeys |
| This area was generated with Dilib version V0.6.23. |  |